The researchers found that mRNA-based COVID-19 vaccines could potentially help patients whose tumors don’t respond well to ...
A team of researchers led by the University of California San Diego has discovered a new way to make yeast cells more ...
An enzyme in the blue blood has been key to testing vaccines since the 1980s, raising concerns for the crabs’ population. But ...
Xencor, Inc. , a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today announced initial results from the ongoing Phase 1 ...
Gilead Sciences approaches Q3 2025 results on October 30, hitting new highs and presenting Livdelzi data at The Liver Meeting ...
The Future of Cellular Regeneration As we advance into 2026, the realm of cellular regeneration has witnessed remarkable innovations that promise to transform our understanding of health, wellness, ...
Background Lupus nephritis (LN) is the most serious complication of SLE. Interstitial fibrosis is the dominant pathological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback